New data on long acting antibody treatment for I... - MPN Voice

MPN Voice

10,445 members14,398 posts

New data on long acting antibody treatment for Immune Compromised

EPguy profile image
1 Reply

I posted this in a reply today, but here is more info. I don't think it's authorized yet in UK even as it is a UK Co. But maybe UK members can clarify.

astrazeneca.com/media-centr...

<<Evusheld received Emergency Use Authorisation (EUA) in the US in December 2021 for the pre-exposure prophylaxis (prevention) of COVID-19 in people with moderate to severe immune compromise due to a medical condition or immunosuppressive medications>>

Anyone on Rux should have good odds to qualify I would expect.

<<Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19>>

<<Evusheld is one of only two antibody therapies authorised for use that showed neutralising activity against Omicron>>

<<The half-life extension more than triples the durability of its action compared to conventional antibodies and could afford up to 12 months of protection from COVID-19 following a single administration>>

It's possible that 12 months prediction could be less for Omicron. But the vaxes are looking like they need regular boosts just the same. If I were to follow my Dr's suggestion to start Rux I would ask about this new agent.

Written by
EPguy profile image
EPguy
To view profiles and participate in discussions please or .
Read more about...
1 Reply
Wewo01 profile image
Wewo01

Thanks for posting this.

You may also like...

Immune system compromised?

Vaccine efficacy for immune compromised?

Hello all ~ yet another Covid-19 question. AARP just sent a message containing, among other facts...

Long term Hydroxycarbamide treatment

New treatment options

that will complement each other in terms of their activity. Novel combinations are looking at...

Email received: New Treatments for Covid.

delivered a PCR test to keep at home and use if I get Covid symptoms. They give instructions with...